Back
Regeneron Pharmaceuticals Stock Price Chart
7 Stocks to Own Before the 2024 Election
Click the link below to get your copy. FREE
Buy
62
REGN
Regeneron Pharmaceuticals
Last Price:
1,023.75
Seasonality Move:
8.73%
7 Day Trial
ALL ACCESS PASS
$
7
20 High-Yield Dividend Stocks that Could Ruin Your Retirement
Sign up now to get this report and avoid a high-yield dividend trap - Yours FREE.- The current trend is moderately bearish and REGN is experiencing slight selling pressure.
Regeneron Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1054.1 | Sell |
| 20-day SMA: | 1036.45 | Sell |
| 50-day SMA: | 988.34 | Buy |
| 200-day SMA: | 911.91 | Buy |
| 8-day EMA: | 1045.32 | Sell |
| 20-day EMA: | 1034.09 | Sell |
| 50-day EMA: | 1002.42 | Buy |
| 200-day EMA: | 922.27 | Buy |
Regeneron Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 16.9 | Buy |
| Relative Strength Index (14 RSI): | 49.53 | Sell |
| Chaikin Money Flow: | -114082 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (994.68 - 1055.62) | Sell |
| Bollinger Bands (100): | (926.42 - 1013.82) | Buy |
Regeneron Pharmaceuticals Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 1,024.09 while REGN 8-day simple moving average is 1,054.10, which is a Sell signal.
- The stock price of REGN is 1,024.09 while Regeneron Pharmaceuticals 20-day SMA is 1,036.45, which makes it a Sell.
- Regeneron Pharmaceuticals 50-day simple moving average is 988.34 while REGN share price is 1,024.09, making it a Buy technically.
- REGN stock price is 1,024.09 and Regeneron Pharmaceuticals 200-day simple moving average is 911.91, creating a Buy signal.
REGN Technical Analysis vs Fundamental Analysis
Buy
62
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a Buy
The current Regeneron Pharmaceuticals [REGN] share price is $1,024.09. The Score for REGN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
112.84B
Price in USD:
1,024.09
Share Volume:
378.06K
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
1,081.17
52-Week Low:
688.52
Buy
62
Regeneron Pharmaceuticals (REGN)
is a Buy
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?
The Regeneron Pharmaceuticals stock price is 1,024.09 USD today. -
Will REGN stock go up or go down?
Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Regeneron Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is not overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 1,024.09 while REGN 8-day exponential moving average is 1,045.32, which is a Sell signal.
- The stock price of REGN is 1,024.09 while Regeneron Pharmaceuticals 20-day EMA is 1,034.09, which makes it a Sell.
- Regeneron Pharmaceuticals 50-day exponential moving average is 1,002.42 while REGN share price is 1,024.09, making it a Buy technically.
- REGN stock price is 1,024.09 and Regeneron Pharmaceuticals 200-day simple moving average is 922.27, creating a Buy signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.94 per share, an increase this year of $1.54 per share, and an increase next year of $3.26 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
- REGN Moving Average Covergence Divergence (MACD) indicator is 16.9, suggesting Regeneron Pharmaceuticals is a Buy
- Regeneron Pharmaceuticals Relative Strength Index (RSI) is 49.53, which suggest Regeneron Pharmaceuticals is oversold
- The Bollinger Bands (25) for Regeneron Pharmaceuticals is (994.68 - 1055.62), which suggest Regeneron Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Regeneron Pharmaceuticals is (926.42 - 1013.82), which suggest Regeneron Pharmaceuticals is a Buy
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.